How many people in the United States were registered to be adult volunteer marrow donors? How many people received bone marrow and cord blood transplants last year? This section provides at-a-glance statistics on donor registry, transplants performed, and transplant outcomes.
Statistics at a glance
- The donor registry contains more than 9.4 million potential donors in the U.S.
- More than 246,500 cord blood units are on the registry. This total includes more than 122,500 units from the National Cord Blood Inventory (NCBI), with more than 200 NCBI units added in 2024.
- In 2022, 5,365 unrelated and 3,981 related bone marrow and cord blood transplants were performed in the United States and reported to CIBMTR.
More than 130,000 cord blood units on the registry in 2024 were from genetically diverse backgrounds:
- American Indian or Alaska Native
- Asian
- Black or African American
- Hispanic or Latino
- Native Hawaiian or Other Pacific Islander
Figure 6. Cord Blood Units on the Registry by Race and Ethnicity
Nearly 3.8 million volunteers on the registry in 2024 were from genetically diverse communities:
- American Indian or Alaska Native
- Asian
- Black or African American
- Hispanic or Latino
- Native Hawaiian or Other Pacific Islander
Figure 4. Diversity of Marrow Donors on the Registry
Figure 5. Marrow Donors on the Registry by Race and Ethnicity
View more data and figures on the Donor Registry Data page.
A total of 22,576 HCTs were performed in the United States and reported to CIBMTR in 2022. Of these, 5,365 (24%) were unrelated transplants and 3,981 (18%) were related transplants.
Peripheral blood stem cells (PBSC) were the most frequently used cell source for all patients in 2022. Bone marrow was used more frequently in patients whose donor was related to them than patients who had an unrelated donor transplant. Umbilical cord blood was used more for patients who had an unrelated donor.
Peripheral Blood | Marrow | Cord Blood | |
---|---|---|---|
Related Donor | 75% | 24% | <1% |
Unrelated Donor | 83% | 11% | 6% |
Seventy-five percent (75%) of the unrelated HCTs and 50% of the related HCTs performed in the United States and reported to CIBMTR in 2022 were for White non-Hispanic recipients.
View the report on transplants performed.
Use the Transplant Center Search tool to find out about the number of transplants performed for certain diseases or transplant centers.
Data collected by the CIBMTR (including data used to meet SCTOD requirements) are used to provide patient survival estimates for a disease at a specific center and also to develop summary slides of outcomes data. The Hematopoietic Cell Transplant Indications and Outcomes page shows the disease-specific indications and outcomes, as well as comparison of HCT outcomes and trends by age, disease stage, and transplant type.
Use the Transplant Center Search tool to review the “Overall center survival” tab for each transplant program and find out about the patient’s survival information for a particular center.
To understand how information from a report applies to your specific situation, talk with your doctor.
If the data needed are not available through these reports, you can submit a customized data request using a CIBMTR Data Request Form.